Flow cytometric evaluation of proliferating cell nuclear antigen expression in human hematopoietic malignancies

Acta Oncologica

Volumn 36, Issue 1, 1997, Pages 17-22

  Erlanson, Martin ^a   Landberg, Göran ^a   Lindh, Jack ^a   Roos, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0030971992     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709100725     Document Type: Article

References (31)

1. Lenner P, Roos G, Johansson H, Lindh J, Dige U. Non-Hodgkin's lymphoma-multivariate analysis of prognostic factors including fraction of S-phase cells. Acta Oncol 1987; 26: 179-83.
2. Silvestrini R, Costa A, Giradini R, et al. Prognostic implications of cell kinetics, histopathology and pathologic state in non-Hodgkin's lymphomas. Hematol Oncol 1989; 7: 411-22.
3. Cowan RA, Harris M, Jones M, Crowther D. DNA content in high and intermediate grade non-Hodgkin's lymphomaprognostic significance and clinicopathological correlations. Br J Cancer 1989; 60: 904-10.
4. Kvaløy S, Godal T, Marton PF, Steen H, Brennhovd IO, Abrahamsen AF. Spontaneous (3H)-thymidine uptake in histological subgroups of human B-cell lymphomas. Scand J Haematol 1981; 26: 221-34.
5. Sebo TJ, Roche PC, Witzig TE, Kurtin PJ. Proliferative activity in non-Hodgkin's lymphomas - A comparison of the Bromodeoxyuridine labeling index with PCNA immunostaining and quantitative image analysis. Am J Clin Pathol 1993; 99: 668-72.
6. Åkerman M, Brandt L, Johnson A, Olsson H. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis. Br J Cancer 1987; 55: 219-23.
7. Hall PA, Richards MA, Gregory WM, D'Ardenne AJ, Lister TA, Stansfeld AG. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 1988; 154: 223-35.
8. Klemi J, Alanamen K, Jalkanen S, Joensuu H. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma. Br J Cancer 1992; 66: 739-43.
9. Swerdlow SH, Westermann CD, Pelstring RJ, Saboorian MH, Williams ME. Growth fraction in centrocytic and follicular centre cell lymphomas: Assessment in paraffin sections with a proliferating cell nuclear antigen antibody and morphometric correlates. Hum Pathol 1993; 24: 540-6.
10. Korkolpoulou P, Oates J, Kittas C, Crocker J. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas. J Clin Pathol 1994; 47: 9-14.
11. Sabattini E, Gerdcs J, Gherlinzoni F, et al. Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J Pathol 1993; 169: 397-403.
12. Lindh J, Jonsson H, Lenner P, Roos G. 'Aggressive' low grade lymphocytic lymphomas can be identified by flow cytometric S-phase determinations. Hematol Oncol 1992; 10: 171-9.
13. Macartney JC, Camplejohn RS. DNA flow cytometry of non-Hodgkin's lymphoma. Eur J Cancer 1990; 26: 635-7.
14. Tan E, Ogata K, Takasaki Y. PCNA/Cyclin: A lupus antigen connected with DNA replication. J Rheumatol 1987; (Suppl 13) 14: 91-6.
15. Bravo R, Macdonald-Bravo H. Existence of two populations of cyclin/proliferaling cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol 1987; 105: 1549-54.
16. Landberg G, Roos G. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells. Cytometry 1992; 6: 230-40.
17. Landberg G, Roos G. Antibodies to proliferating cell nuclear antigen (PCNA) as S-phase probes in flow cytometric cell cycle analysis. Cancer Res 1991; 51: 4570-4.
18. Begg AC, McNally NJ, Shrieve DC, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 620-2.
19. Gerhard-Marchant R. Hamlin I, Lennert K, Rilke F, Stansfeld AG, van Unnick JAM. Classification of non-Hodgkin's lymphomas. Lancet 1974; 2: 406-8.
20. Benett JM, Catovsky D, Churchill WH, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British co-operative group. Ann Intern Med 1985; 103; 620-5.
21. Vindeløv LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323-7.
22. Erlanson M, Lindh J, Zackrisson B, Landberg G, Roos G. Cell kinetic analysis of non-Hodgkin's lymphoma using in vivo iododeoxyuridine incorporation and flow cytometry. Hemat Oncol 1995; 13: 207-17.
23. Wilson GD, Camplejohn RS, Martindale CA, Brock A, Lande DP, Barnes DM. Flow cytometric characterisation of proliferating cell nuclear antigen using the monoclonal antibody PC10. Eur J Cancer 1992; 28A: 2010-7.
24. Roos G, Landberg G, Huff J, et al. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies using synthetic peptides. Lab Invest 1993; 62: 204-10.
25. Landberg G, Roos G. Expression of proliferating cell nuclear antigen (PCNA) and KI-67 antigen in human hematopoietic cells. Acta Oncol 1991; 30: 917-21.
26. Steel G. Growth kinetics of tumours. London: Oxford University Press, 1977.
27. Motukura T, Arnold A. Cyclins and oncogenesis. Biochim Biophys Acta 1993; 1155: 63-78.
28. Ohtsubo M, Theodoras A, Schumacher J. Roberts J, Pagano M. Human cyclin E. a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 1995; 15: 2612-24.
29. Almasan A, Linke S, Paulsson T, Huang L, Wahl G. Genetic instability as a consequence of inappropriate entry into and progression through S-phase. Cancer and Metastasis Reviews 1995; 14: 59-73.
30. Kaufmann W. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer and Metastasis Reviews 1995; 14: 31-41.
31. Murnane JP, Painter RB. Complementation of the defects of DNA synthesis in irradiated and unirradiated ataxia-telangiectasia cell line. Proc Natl Acad Sci USA 1982; 79: 1960-3.